May 22, 2026 · Form 4 insider transaction
VON RICKENBACH JOSEF H bought 15,950 shares of Rein Therapeutics Inc. at $1.05 per share, a transaction worth $16.7K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 6 days after the transaction.
The reported shares were purchased in the open market in multiple transactions at prices ranging from $1.05 and $1.035 on May 21, 2026, $1.07 and $1.01 on May 22, 2026, $1.07 and $1.03 on May 26, 2026 and $1.08 and $1.03 on May 27, 2026. The prices reported in Column 4 are a weighted average price for purchase on the respective day. The reporting person undertakes to provide to Rein Therapeutics, Inc., any stockholder of Rein Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1).